How to Help Your Patients Find Janumet in Stock: A Provider's Guide

Your Patients Can't Find Janumet. Here's How You Can Help.

When patients call your office saying they can't fill their Janumet prescription, it creates a cascade of problems: missed doses, worsening glycemic control, frustrated phone calls, and staff time spent tracking down alternatives. As a prescriber, you're in a unique position to help your patients navigate these access challenges efficiently.

This guide provides a practical, step-by-step approach to helping patients find Janumet (Sitagliptin/Metformin) in stock — and what to do when it simply isn't available.

Current Availability: What You Need to Know

Janumet is not on the FDA's drug shortage list, but intermittent stock-outs at individual pharmacies are a reality in 2026. Key factors driving these issues include:

• Single-source manufacturing: Merck is the only manufacturer of Janumet and Janumet XR
• No generic available: The Sitagliptin patent doesn't expire until November 24, 2026
• High cost: At $600-$750/month cash price, some pharmacies limit the quantity they stock
• Distributor allocation: During high-demand periods, pharmacies may receive partial orders

Understanding these dynamics helps you set realistic expectations with patients and develop proactive strategies.

Why Patients Can't Find Janumet

From the patient's perspective, the pharmacy experience can be confusing and frustrating. Common scenarios include:

• The pharmacy says "we don't carry it" (a stocking decision, not a shortage)
• The pharmacy is temporarily out and waiting on a distributor shipment
• The patient's usual pharmacy closed or changed ownership
• Insurance changed and the new preferred pharmacy doesn't stock Janumet
• The patient waited too long to refill and is now urgently searching

Most of these situations are solvable with the right approach.

5 Steps to Help Patients Find Janumet

Step 1: Use Medfinder to Locate Stock

Medfinder for Providers is a free tool that shows which pharmacies near your patient's location currently have Janumet in stock. Your front office or clinical staff can run a quick search and provide the patient with 2-3 pharmacy options before they leave the office.

Integrating Medfinder into your workflow takes seconds and can prevent the cycle of failed fills, callback requests, and prior authorization delays.

Step 2: E-Prescribe to a Pharmacy With Stock

Once you've identified a pharmacy with Janumet in stock, send the prescription electronically. This is faster and more reliable than asking the patient to call their pharmacy and request a transfer. If the patient's usual pharmacy is out, simply send to the next closest option with confirmed stock.

Step 3: Prescribe Both Formulations If Appropriate

Consider noting on the chart (and informing the patient) that either Janumet or Janumet XR may be acceptable. If the pharmacy is out of one formulation, the patient can ask about the other:

• Janumet: 50mg/500mg, 50mg/850mg, or 50mg/1000mg — twice daily with meals
• Janumet XR: 50mg/500mg, 50mg/1000mg, or 100mg/1000mg — once daily with evening meal

Switching between formulations is clinically straightforward, though the total daily dose should remain consistent. Janumet XR may also improve adherence for patients who struggle with twice-daily dosing.

Step 4: Set Up 90-Day Prescriptions

Encourage patients to use 90-day fills through mail-order or retail pharmacies that offer this option. Benefits include:

• Fewer opportunities for stock-out disruptions
• Mail-order pharmacies typically maintain larger inventories
• Many insurance plans offer lower per-fill copays for 90-day supplies
• Reduces the number of refill-related calls to your office

Step 5: Activate Savings Programs at Point of Prescribing

Cost is a major reason patients don't fill prescriptions. Help them access savings before they leave your office:

• Merck savings card: Eligible commercially insured patients can pay as little as $5/fill — enroll at janumetxr.com/special-offers
• Merck Patient Assistance Program: Free medication for eligible uninsured/underinsured patients — apply at merckhelps.com
• Discount cards: GoodRx, SingleCare, and RxSaver may reduce costs for uninsured patients

Having savings card information pre-printed or available as a handout in exam rooms streamlines this process. For a comprehensive overview, see our provider's guide to helping patients save money on Janumet.

When to Consider Alternatives

If Janumet is consistently unavailable or cost-prohibitive for a patient, these alternatives provide similar therapeutic coverage:

DPP-4 Inhibitor/Metformin Combinations

• Jentadueto (Linagliptin/Metformin): No renal dose adjustment for Linagliptin component — useful for patients with eGFR 30-45. Available as twice-daily (Jentadueto) or once-daily (Jentadueto XR).
• Kombiglyze XR (Saxagliptin/Metformin ER): Once-daily dosing. Be aware of the SAVOR-TIMI 53 heart failure signal with Saxagliptin — use caution in patients with heart failure history.
• Kazano (Alogliptin/Metformin): Twice-daily dosing. Generally well-tolerated with a similar side effect profile to Janumet.

Component-Based Approach

Prescribing Januvia (Sitagliptin) + generic Metformin as separate tablets provides the same active ingredients. Advantages include independent dose titration and the availability of inexpensive generic Metformin ($4-$10/month). The trade-off is that Januvia alone costs $500-$600/month without insurance.

Different Medication Classes

For patients who may benefit from a class change:

• SGLT2 inhibitor + Metformin combinations (Synjardy, Xigduo XR) — offer cardiovascular and renal benefits
• GLP-1 receptor agonists — may be appropriate for patients who would benefit from weight loss
• Generic sulfonylurea + Metformin — much less expensive but carries higher hypoglycemia risk

Review our patient resource on alternatives to Janumet for details to share with patients.

Workflow Tips for Your Practice

Create a Janumet Access Protocol

Develop a standard workflow for your front office when patients report they can't fill Janumet:

1. Check Medfinder for nearby pharmacy stock
2. Offer to e-prescribe to a pharmacy with confirmed availability
3. If no local stock, check whether Janumet XR is available as a substitute
4. If neither is available, schedule a brief provider consultation for alternative options
5. Document the access issue in the chart for tracking patterns

Proactive Patient Communication

For patients currently on Janumet, consider proactively sharing:

• The importance of refilling before running out (7-10 day lead time)
• Merck savings card information if they're not already enrolled
• The Medfinder tool for self-service stock checks: how to check if a pharmacy has Janumet in stock

Track Access Issues

If multiple patients report difficulty finding Janumet, this data can inform your formulary committee, help you anticipate prescribing pattern changes, and prepare for the generic transition expected in late 2026.

Final Thoughts

Janumet access challenges are manageable with a proactive, systematic approach. By incorporating tools like Medfinder, activating savings programs, and having alternative protocols ready, your practice can minimize disruptions to patient care.

The anticipated generic entry in late 2026 or early 2027 should significantly improve both cost and availability. In the meantime, the strategies outlined above will help your patients stay on track with their diabetes management.

For more on the broader shortage picture, see our provider briefing on Janumet availability in 2026.